The NexTGen team is supported through the Cancer Grand Challenges initiative. Learn more here

The NexTGen team is supported through the Cancer Grand Challenges initiative. Learn more here

Washington Post: To save children with cancer, doctors turn to new weapons

January 11, 2023

Washington Post: To save children with cancer, doctors turn to new weapons

January 11, 2023
;

This article, published in the Washington Post focuses on new initiatives brought about via advocacy such as incentivizing pharmaceutical companies to focus on drug development for kids. It also highlights the NexTGen missionto devise new T-cell therapies for children with solid tumours such as rhabdomyosarcoma. Professor Catherine Bollard comments in the piece and organisations that NexTGen advocates have founded are referenced. Please click here to read the full article.

 

Related Posts

NexTGen Annual Research Meeting 2023

NexTGen Annual Research Meeting 2023

On 7th and 8th November 2023, the NexTGen team gathered at the Children’s National Hospital Research and Innovation Campus in Washington DC for their second annual research meeting. More than 80 NexTGen team members attended the event in person, with more joining...

Meet the Researcher: Dr Christina Burke, UCL

Meet the Researcher: Dr Christina Burke, UCL

Dr Christina Burke commented: The treatment options for rhabdomyosarcoma remain harsh, intensive and, in many cases, ineffective. With Alice’s Arc, we hope to translate the success of CAR T-cell immunotherapy to this childhood cancer. My goal is to understand how we...

Loading...
NexTGen